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INTRODUCTION AND OBJECTIVES:
Overactive bladder is associated with the metabolic syndrome. Increased succinate production is detected in the presence of hyperglycemia and hypoxemia, as with diabetes mellitus and metabolic syndrome. Succinate was recently identified as a major metabolic switch controlling metabolic functions in the body through its receptor GPR91 (SUCNR1). The aim of our study is to determine how succinate interacts with urothelial cells through its receptor.
METHODS: Urothelial cells were isolated from female Sprague-Dawley rat bladder using a collagenase IV method. After confluency, cells were exposed to succinate then treated for microscopy and immunoblotting. Cyclic AMP and PGE 2 were measured using an Elisa kit from Cayman Chemical Company. Nitric oxide was assessed by an colorimetric method. Retroviruses were generated for shRNA-mediated knockdown of GPR91.
RESULTS: Urothelial cells were characterized using Cytokeratin 17 and the AE1/AE3 antibody. RT-PCR confirmed expression of GPR91. Short-term incubation of cells with succinate (200 mM) results in phosphorylation of Erk and c-Jun amino-terminal kinases (JNKs). Inhibition of the MAPK pathway by PD98059 (10 mM) inhibited increases of Erk-P elicited by succinic acid. On the other hand, pre-incubation of cells with succinate dose-dependently decreased the concentrations of intracellular cyclic AMP stimulated by forskolin. Succinate triggers entry of calcium inside urothelial cells as visualized by confocal microscopy. Long-term incubation of cells with succinate increased secretion of nitric oxide and decreased PGE 2 release. Cells infected with shRNA retrovirus targeting GPR91 displayed a strong decrease in GPR91 expression. This was associated with a loss of succinate-stimulated Erk phosphorylation. Moreover, inhibition of cyclic AMP synthesis, increases in intracellular calcium and release of nitric oxide were all dramatically prevented.
CONCLUSIONS: GPR91 is expressed in urothelial cells. Binding of succinate to its receptor triggers phosphorylation of Erk and JNK, a process that requires the MAPK pathway. Inhibition of cyclic AMP production suggests the receptor is bound to protein G i . Release of nitric oxide and decrease of PGE 2 are under succinic acid control suggesting a potential cross-talk between urothelium and detrusor muscle. Notably, upon stimulation with CCh, DSM force rises rapidly to a peak value, then gradually declines (fades) despite the continued presence of CCh. The mechanism behind the fade in force s not understood. There is evidence that, in addition to causing contraction, muscarinic receptor stimulation can activate AMPK, and AMPK has been shown to negatively regulate smooth muscle contraction. The purpose of this study was to test the hypothesis that DSM contraction fade is due to the delayed activation of AMPK.
METHODS: Mouse bladder with mucosa were cut into rings~3 mm wide, and strips of DSM free from underlying mucosa were removed from rabbit bladders. Each tissue was placed in an organ bath connected to a force transducer and length-adjuster and subjected to a length-tension protocol to identify the length (Lref) that produced the strongest active force induced by KCl. Each ring was subsequently set to 95% Lref. Three tissues were then contracted by exposure to 10 microM CCh and quick-frozen at 5, 30 and 180 seconds. A fourth tissue was not contracted and quick-frozen to assess the basal-state. Tissues were subsequently processed to quantify the level of phosphoproteins that are indices of activation of AMPK (ACC-pS79 and AMPK-p172) and of actomyosin crossbridges (MLC-pS19 and MYPT1-pT853).
RESULTS: Compared to the basal-state, CCh induced a strong increase in force in mouse bladder and rabbit DSM that peaked at, respectively, 60 sec and 20 sec, before declining to~50% of the peak values within 180 sec (n¼3). MLC-p also displayed a biphasic response. AMPK-pand ACC-p displayed a delayed increase corresponding with the decrease in contractile force.
CONCLUSIONS: Muscarinic receptor stimulus CCh caused a rapid increase in force in mouse bladder and rabbit DSM that faded with time despite the presence of CCh. This fade in force correlated with a delayed increase in AMPK activity as assessed by increases in the phosphoproteins, ACC-p and AMPK-p. Because AMPK has been shown to inhibit smooth muscle contraction, the correlation of an increase in AMPK activity with the decrease in force supports the hypothesis that AMPK may be responsible for fade in DSM force. Because AMPK activity is also elevated during ischemia/hypoxia, a condition Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 THE JOURNAL OF UROLOGY â e1253 known to cause bladder underactivity, these data warrant further studies to investigate the potential role of AMPK in bladder underactivity 
In our initial review of the Trauma Outcomes and Urogenital Health (TOUGH) cohort, we identified 423 male US service members (SMs) who sustained penile injuries (PI) while deployed in support of Operations Iraqi Freedom and Enduring Freedom (OIF/OEF). Conventional penile reconstruction is challenged by the unique structure and function of the penile tissues. Thus, penile transplantation is being investigated as a potential means for penile replacement after severe PI. We have made the clinical observation that many SMs who sustained severe PI during OIF/OEF presented with complex polytrauma which may have excluded them from enrollment in existing penile transplantation protocols. The objective of this study was to evaluate the injury patterns among members of the TOUGH cohort who sustained PI with a focus on comorbid conditions which may impact candidacy for penile transplantation.
METHODS: The previously identified members of the TOUGH cohort who sustained PI were further characterized based on injury severity as well as the presence of comorbid conditions which may impact eligibility for penile transplantation. Severe PI was defined as an Abbreviated Injury Scale severity of 3 or greater (cutaneous avulsion, laceration through glans/cavernosum/urethra, or partial/total penectomy). Five comorbid conditions were identified which may negatively impact penile transplant candidacy: traumatic brain injury (TBI), massive blood transfusion, colorectal injury, pelvic fracture, and extremity amputation(s). SMs with severe PI were stratified by the number of comorbid conditions diagnosed.
RESULTS: Among the 423 men with PI identified in the TOUGH cohort, 86 (20.3%) sustained severe PI. SMs with severe PI were largely young (median age: 23) and injured during battle (n¼81; 94%) by explosive mechanisms (n¼77; 90%) resulting in severe polytrauma (median ISS¼29). Comorbid conditions which could impact penile transplantation candidacy were common, including massive transfusion (n¼56; 65%), lower extremity amputation(s) (n¼55; 64%), TBI (n¼34; 40%), colorectal injury (n¼29; 34%), and pelvic fracture (n¼27; 31%). Overall, 83% of SMs (n¼71) had at least one of these conditions and 47% (n¼41) had 3. CONCLUSIONS: Severe PI was relatively rare during OIF/OEF. Life-threatening polytrauma was common and nearly all SMs with severe PI had comorbid immunologic, physical, and/or neurologic diagnoses which could disqualify them from penile transplantation given the current restrictions identified in existing transplant protocols.
Source of Funding: none; The view(s) expressed herein are those of the author(s) and do not reflect the official policy or position of Brooke Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army or the Department of Defense or the U.S. Government.
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INTRODUCTION AND OBJECTIVES: In AAST grade IV and V injuries or grade III injury with perinephric fluid, current guidelines recommend obtaining a CT scan of abdomen and pelvis with intravenous contrast, followed by a delayed excretory phase to look for collecting system injury. Our aim was to evaluate compliance with excretory phase imaging recommendations in a contemporary multicenter study of high-grade renal trauma.
METHODS: From 2014 to 2016, data on high-grade renal trauma (AAST grade III-V) was gathered from 10 participating trauma centers. Demographics, trauma characteristics, management, outcomes, and imaging studies, were collected. Compliance with imaging recommendations was defined as obtaining delayed excretory images within 24 hours of admission for any grade IV or V injury, or grade III injuries with perinephric fluid, in those patients not undergoing immediate laparotomy. Follow-up images and data were reviewed to determine if there were cases of delayed diagnosis of urinary extravasation.
RESULTS: There were 217 high-grade renal injuries (grades III [118], IV [69], V [30]). Initial CT scans were missing in 49 patients due to: patient transfer and unavailable initial imaging (15), or immediate laparotomy (34). 168 patients had an initial CT scan for review. From these, 161 had CT findings indicating the need for excretory imaging due to perinephric fluid in grade III (98), or grade IV (48) or V (15) injury. 112 (70%) of these patients had excretory imaging within 24 hours of admission, an additional 10 (6%) had one obtained during their initial hospital stay (range 2-6 days post injury). Of the patients with excretory imaging 37 (31%) had a collecting system injury diagnosed in initial CT scan with additional 3 (2%) diagnosed in CT scans obtained later during their initial hospital stay. Overall compliance with imaging recommendations ranged between 20%-100% (median: 81%) for different centers. Of 39 patients who did not have an excretory imaging, 5 underwent a CT with excretory phase later, and 2 had a delayed diagnosis of urinary leakage.
CONCLUSIONS: There is discrepancy between centers in compliance with obtaining excretory phase CT scans for evaluation of high-grade renal trauma. Despite the variation in compliance with imaging recommendations, the rate of clinically significant delayed diagnosis of urinary extravasation is low in the overall management of highgrade renal injury.
